Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

NCT07342803 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Asthma

Interventions

BIOLOGICAL: LP-003 Injection
BIOLOGICAL: Omalizumab
BIOLOGICAL: Placebo

Sponsor

Longbio Pharma